Floatz logo

Medroxyprogesterone

Osteoporosis

Peking Union Medical College HospitalSmall moleculePhase 4 / ApprovedDormant
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
60/ 100
Competitive Position
89/ 100

Competitive context

6 Active assets in the Osteoporosis cohort.

Asset / SponsorPhaseRating
RISEDRONIC ACID
Susan L. Greenspan
Phase 4BBB
Zoledronate
California Pacific Medical Center Research Institute
Phase 4BBB
VITAMIN D
Benha University
Phase 4BBB
ALENDRONIC ACID
University College Dublin
Phase 4BBB
Calcium
Benha University
Phase 4BBB

View all 50 →

Same molecule, other indications

Medroxyprogesterone is also rated in:

cardiovascular disorderDormant
BB
Indicative · Phase 4
65 / 100
View asset →
sickle cell diseaseActive
BB
Indicative · Phase 4
65 / 100
View asset →
prostate adenocarcinomaDormant
BB
Indicative · Phase 3
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →